These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32473757)

  • 21. Locoregional Therapy of Hepatocellular-Cholangiocarcinoma versus Hepatocellular Carcinoma: A Propensity Score-Matched Study.
    Huang YH; Park BV; Chen YF; Gaba RC; Guzman G; Lokken RP
    J Vasc Interv Radiol; 2019 Sep; 30(9):1317-1324. PubMed ID: 31375450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant Yttrium-90 Transarterial Radioembolization with Resin Microspheres Prescribed Using the Medical Internal Radiation Dose Model for Intrahepatic Cholangiocarcinoma.
    Sarwar A; Ali A; Ljuboja D; Weinstein JL; Shenoy-Bhangle AS; Nasser IA; Morrow MK; Faintuch S; Curry MP; Bullock AJ; Ahmed M
    J Vasc Interv Radiol; 2021 Nov; 32(11):1560-1568. PubMed ID: 34454031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Segmental Yttrium-90 Radioembolization Using Glass Microspheres Greater than 400 Gray for the Treatment of Intrahepatic Cholangiocarcinoma: A Preliminary Experience.
    Yu Q; Patel M; Kwak D; Ungchusri E; Wang Y; Van Ha T; Zangan S; Marshall E; Little K; Baker T; Liao CY; Pillai A; Ahmed O
    J Vasc Interv Radiol; 2023 Nov; 34(11):1970-1976.e1. PubMed ID: 37532096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Change in total lesion glycolysis and clinical outcome after (90)Y radioembolization in intrahepatic cholangiocarcinoma.
    Filippi L; Pelle G; Cianni R; Scopinaro F; Bagni O
    Nucl Med Biol; 2015 Jan; 42(1):59-64. PubMed ID: 25213104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transarterial Yttrium-90 Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis.
    Schartz DA; Porter M; Schartz E; Kallas J; Gupta A; Butani D; Cantos A
    J Vasc Interv Radiol; 2022 Jun; 33(6):679-686. PubMed ID: 35219834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Choi criteria and Response Evaluation Criteria in Solid Tumors (RECIST) for intrahepatic cholangiocarcinoma treated with glass-microspheres Yttrium-90 selective internal radiation therapy (SIRT).
    Beuzit L; Edeline J; Brun V; Ronot M; Guillygomarc'h A; Boudjema K; Gandon Y; Garin E; Rolland Y
    Eur J Radiol; 2016 Aug; 85(8):1445-52. PubMed ID: 27423686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular Carcinoma.
    Allimant C; Kafrouni M; Delicque J; Ilonca D; Cassinotto C; Assenat E; Ursic-Bedoya J; Pageaux GP; Mariano-Goulart D; Aho S; Guiu B
    J Vasc Interv Radiol; 2018 Dec; 29(12):1662-1670.e4. PubMed ID: 30217745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of 3 Different Therapeutic Particles in Radioembolization of Locally Advanced Intrahepatic Cholangiocarcinoma.
    Wagemans MEHM; Kunnen B; Stella M; van Rooij R; Smits M; Bruijnen R; Lam MGEH; de Jong HWAM; Braat AJAT
    J Nucl Med; 2024 Feb; 65(2):272-278. PubMed ID: 38176716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transarterial Radioembolization Treatment of Pancreatic Cancer Patients with Liver-Dominant Metastatic Disease Using Yttrium-90 Glass Microspheres: A Single-Institution Retrospective Study.
    Kayaleh R; Krzyston H; Rishi A; Naziri J; Frakes J; Choi J; El-Haddad G; Parikh N; Sweeney J; Kis B
    J Vasc Interv Radiol; 2020 Jul; 31(7):1060-1068. PubMed ID: 32534978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-Life Experience in the Treatment of Intrahepatic Cholangiocarcinoma by
    Schaarschmidt BM; Kloeckner R; Dertnig T; Demircioglu A; Müller L; Auer TA; Santos DPD; Steinle V; Miederer M; Gebauer B; Radunz S; Kasper S; Weber M; Theysohn J
    J Nucl Med; 2023 Apr; 64(4):529-535. PubMed ID: 36328487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis.
    Al-Adra DP; Gill RS; Axford SJ; Shi X; Kneteman N; Liau SS
    Eur J Surg Oncol; 2015 Jan; 41(1):120-7. PubMed ID: 25449754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioembolization with Yttrium-90 Microspheres for the Treatment of Liver Metastases of Pancreatic Adenocarcinoma: A Multicenter Analysis.
    Kim AY; Frantz S; Brower J; Akhter N
    J Vasc Interv Radiol; 2019 Mar; 30(3):298-304.e2. PubMed ID: 30819469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Factors in Overall Survival of Patients with Unresectable Intrahepatic Cholangiocarcinoma Treated by Means of Yttrium-90 Radioembolization: Results in Therapy-Naïve Patients.
    Reimer P; Virarkar MK; Binnenhei M; Justinger M; Schön MR; Tatsch K
    Cardiovasc Intervent Radiol; 2018 May; 41(5):744-752. PubMed ID: 29344713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioembolization with (90)Y resin microspheres for intrahepatic cholangiocellular carcinoma: prognostic factors.
    Soydal C; Kucuk ON; Bilgic S; Ibis E
    Ann Nucl Med; 2016 Jan; 30(1):29-34. PubMed ID: 26370716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PET response criteria for solid tumors predict survival at three months after intra-arterial resin-based 90Yttrium radioembolization therapy for unresectable intrahepatic cholangiocarcinoma.
    Camacho JC; Kokabi N; Xing M; Schuster DM; Kim HS
    Clin Nucl Med; 2014 Nov; 39(11):944-50. PubMed ID: 25140563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study.
    Mosconi C; Gramenzi A; Ascanio S; Cappelli A; Renzulli M; Pettinato C; Brandi G; Monari F; Cucchetti A; Trevisani F; Golfieri R
    Br J Cancer; 2016 Jul; 115(3):297-302. PubMed ID: 27336601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective internal radiation therapy using yttrium-90 microspheres for treatment of localized and locally advanced intrahepatic cholangiocarcinoma.
    Yu Q; Ungchusri E; Pillai A; Liao CY; Baker T; Fung J; DiSabato D; Zhang M; Liao C; Van Ha T; Ahmed O
    Eur Radiol; 2024 Apr; 34(4):2374-2383. PubMed ID: 37812295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modified Radiation Lobectomy Strategy of Radioembolization for Right-Sided Unresectable Primary Liver Tumors.
    Yu Q; Wang Y; Ungchusri E; Pillai A; Liao CY; Fung J; DiSabato D; Baker T; Patel M; Van Ha T; Ahmed O
    J Vasc Interv Radiol; 2024 Jul; 35(7):989-997.e2. PubMed ID: 38490364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there a role for Ytrrium-90 in the treatment of unresectable and metastatic intrahepatic cholangiocarcinoma?
    Shaker TM; Chung C; Varma MK; Doherty MG; Wolf AM; Chung MH; Assifi MM
    Am J Surg; 2018 Mar; 215(3):467-470. PubMed ID: 29395023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yttrium-90 Radioembolization in Unresectable Intrahepatic Cholangiocarcinoma: Results of a Multicenter Retrospective Study.
    Bargellini I; Mosconi C; Pizzi G; Lorenzoni G; Vivaldi C; Cappelli A; Vallati GE; Boni G; Cappelli F; Paladini A; Sciuto R; Masi G; Golfieri R; Cioni R
    Cardiovasc Intervent Radiol; 2020 Sep; 43(9):1305-1314. PubMed ID: 32642986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.